Date and Time: November 19, 2025 | 12:00 pm - 1:00 pm Eastern Time

Webinar Description:
Occupational therapists play a critical role in improving independence, function, and quality of life for people living with neuromuscular disorders. This webinar will highlight the latest insights from Muscular Dystrophy Canada (MDC) on the needs of individuals with neuromuscular disease, with a focus on assistive devices, technologies, and the policy landscape that shapes access.

You will leave with a better understanding of the costs of living with neuromuscular disease, current gaps and opportunities in function tracking/assessment, and the role occupational therapy can play in addressing these challenges. You will also learn about the value of building a community of practice that connects clinicians, researchers, and advocates to advance equitable care and innovative solutions.

By the end of this webinar you will:

• Understand the unique needs of individuals with neuromuscular disorders and the role of occupational therapy in supporting function and independence.
• Recognize current challenges and policy considerations related to access to assistive devices, technologies, and supports.
• Examine the financial and social costs of living with neuromuscular disease and their impact on care planning.
• Explore approaches to function tracking and their value for clinical practice and health system decision-making.
• Appreciate the benefits of building and engaging in a community of practice to advance care, collaboration, and advocacy.

Presenter:
Dr. Homira Osman is Vice President of Research and Public Policy at Muscular Dystrophy Canada (MDC), where she leads national initiatives to advance neuromuscular research, care, and policy. She also co-leads the Neuromuscular Disease Network for Canada (NMD4C), shaping strategy and integrating patient and clinician perspectives across research and clinical work.

At MDC, Dr. Osman oversees the national research agenda, knowledge translation, and clinical partnerships, driving equitable, patient-centered health policy. She has led advocacy campaigns, health economic studies, and regulatory submissions that expanded drug access and secured newborn screening for spinal muscular atrophy. Under her leadership, MDC has strengthened internal research capacity, developed impact tracking systems, and advanced readiness for emerging innovations such as gene therapies.

Dr. Osman holds a PhD in Neuroscience, a clinical doctorate in Audiology, and an Honours BSc in Neuroscience and Population Health. She is widely recognized for her leadership in research, policy, and knowledge mobilization.

Fees: (All fees are plus HST)

Refund Policy

OSOT Event Disclaimer

NOTE:  After clicking "Register Myself" your registration will not be complete until you click the "Proceed to Checkout" button.

The presentation will be recorded and will be available to watch on OSOT's Archived Webinars page shortly after the event.